Eutopic endometrial interleukin-18 system mRNA and protein expression at the level of endometrial-myometrial interface in adenomyosis patients

Fertility and Sterility

Volumn 94, Issue 1, 2010, Pages 33-39

  Huang, Hong Yuan ^a,b   Yu, Hsing Tse ^a   Chan, She Hung ^b   Lee, Chyi Long ^a,b   Wang, Hsin Shih ^a,b   Soong, Yung Kuei ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

adenomyosis; cytokine; endometrium; Interleukin 18; PCR

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 18 RECEPTOR;

ADENOMYOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; MYOMETRIUM; POLYMERASE CHAIN REACTION; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERUS MYOMA;

ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-18; MYOMETRIUM; RECEPTORS, INTERLEUKIN-18; RNA, MESSENGER; UP-REGULATION;

EID: 77952547272     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.01.132     Document Type: Article

References (37)

1. Arici A. Local cytokines in endometrial tissue: the role of interleukin-8 in the pathogenesis of endometriosis. Ann N Y Acad Sci 955 (2002) 101-109
2. Snesky T.E., and Liu D.T. Endometriosis: associations with menorrhagia, infertility, and oral contraceptives. Int J Gynaecol Obstet 17 (1980) 573-576
3. Sampson J.A. Peritoneal endometriosis because of menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14 (1927) 422-469
4. Hill J., and Anderson D. Lymphocyte activity in the presence of peritoneal fluid from fertile women and infertile women with endometriosis. Am J Obstet Gynecol 161 (1989) 861-864
5. Ferenczy A. Pathophysiology of adenomyosis. Hum Reprod Update 4 (1998) 312-322
6. Kitawaki J. Adenomyosis: the pathophysiology of an oestrogen-dependent disease. Best Pract Res Clin Obstet Gynaecol 20 (2006) 493-502
7. Bergeron C., Amant F., and Ferenczy A. Pathology and physiopathology of adenomyosis. Best Pract Res Clin Obstet Gynaecol 20 (2006) 511-521
8. Ota H., Igarashi S., Hatazawa J., and Tanaka T. Is adenomyosis an immune disease?. Hum Reprod Update 4 (1998) 360-367
9. Marcus C. Relationship of adenomyosis uteri to endometrial hyperplasia and endometrial carcinoma. Am J Obstet Gynecol 82 (1961) 408-416
10. Uduwela A.S., Perera M.A., Aiqing L., and Fraser I.S. Endometrial-myometrial interface: relationship to adenomyosis and changes in pregnancy. Obstet Gynecol Surv 55 (2000) 390-400
11. Yoshino O., Osuga Y., Koga K., Tsutsumi O., Yano T., Fujii T., et al. Evidence for the expression of interleukin-18, IL-18 receptor and IL-18 binding protein in the human endometrium. Mol Hum Reprod 7 (2001) 649-654
12. Huang H.Y., Chan S.H., Yu H.T., Wang H.S., Lai C.H., and Soong Y.K. Interleukin-18 system messenger ribonucleic acid and protein expression in human endometrium during menstrual cycle. Fertil Steril 86 (2006) 905-913
13. Dinarello C.A. Interleukin-18. Methods 19 (1999) 123-132
14. Akira S. The role of IL-18 in innate immunity. Curr Opin Immunol 12 (2000) 59-63
15. Okamura H., Tsutsui H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., et al. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378 (1995) 88-91
16. Ghayur T., Banerjee S., Hugunin M., Butler D., Herzog L., Carter A., et al. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature 386 (1997) 619-623
17. Nakanishi K., Yoshimoto T., Tsutsui H., and Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19 (2001) 423-474
18. Kato Z., Jee J., Shikano H., Mishima M., Ohki I., Ohnishi H., et al. The structure and binding mode of interleukin-18. Nat Struct Biol 10 (2003) 966-971
19. Novick D., Kim S.-H., Fantuzzi G., Reznikov L., Dinarello C.A., and Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10 (1999) 127-136
20. Arici A., Matalliotakis I., Goumenou A., Koumantakis G., Vassiliadis S., and Mahutte N.G. Altered expression of interleukin-18 in the peritoneal fluid of women with endometriosis. Fertil Steril 80 (2003) 889-894
21. Oku H., Tsuji1 Y., Kashiwamura S.I., Adachi S., Kubota A., Okamura H., et al. Role of IL-18 in pathogenesis of endometriosis. Hum Reprod 19 (2004) 709-714
22. Zhang X., Lin J., Qian Y., and Deng L. Decreased levels of interleukin-18 in peritoneal fluid but not in serum of patients with endometriosis. Fertil Steril 81 (2004) 1229-1234
23. Luo Q., Ning W., Wu Y., Zhu X., Jin F., Sheng J., et al. Altered expression of interleukin-18 in the ectopic and eutopic endometrium of women with endometriosis. J Reprod Immunol 72 (2006) 108-117
24. Huang H.Y., Wen Y., Irwin J.C., Kruessel J.S., Soong Y.K., and Polan M.L. Cytokine-mediated regulation of 92-kilodalton type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-3 messenger ribonucleic acid expression in human endometrial stromal cells. J Clin Endocrinol Metab 83 (1998) 1721-1729
25. Huang H.Y., Chan S.H., Wu C.H., Wang C.W., Lai C.H., and Soong Y.K. Interleukin-1 system messenger ribonucleic acid and protein expression in human fallopian tube may be associated with ectopic pregnancy. Fertil Steril 84 (2005) 1484-1492
26. Tabibzadeh S.S. Human endometrium: an active site of cytokine production and action. Endocr Rev 12 (1991) 272-290
27. Gazvani R., and Templeton A. Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction 123 (2002) 217-226
28. Bedaiwy M.A., and Falcone T. Peritoneal fluid environment in endometriosis: clinicopathological implications. Minerva Ginecol 55 (2004) 333-345
29. Nakanishi K., Yoshimoto T., Tsutsui H., and Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 12 (2001) 53-72
30. Xu D., Chan W.L., Leung B.P., Hunter D., Schulz K., Carter R.W., et al. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J Exp Med 188 (1998) 1485-1492
31. Bird C.C., McElin T.W., and Manalo-Estrella P. The elusive adenomyosis of the uterus. Am J Obstet Gynecol 112 (1972) 583-593
32. Brosens J.J., De Souza N.M., and Barker F.G. Uterine junctional zone: function and disease. Lancet 346 (1995) 558-560
33. Giudice L. Endometriosis. Lancet 364 (2004) 1789-1799
34. Khorram O., Taylor R., Ryan I., Schall T., and Landers D. Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. Am J Obstet Gynecol 169 (1993) 1545-1549
35. Simón C., Piquette G.N., Frances A., and Polan M.L. Localization of interleukin-1 type I receptor and interleukin-l β in human endometrium throughout the menstrual cycle. J Clin Endocrinol Metab 77 (1993) 549-555
36. Simón C., Frances A., Lee B.Y., Mercader A., Huynh T., Remohi J., et al. Immunohistochemical localization, identification and regulation of the interleukin-1 receptor antagonist in the human endometrium. Hum Reprod 10 (1995) 2472-2477
37. Huang H.Y., Wen Y., Kruessel J.S., Raga F., Soong Y.K., and Polan M.L. Interleukin-1β (IL-1β) regulation of IL-1β and interleukin-1 receptor antagonist (IL-1ra) expression in cultured human endometrial stromal cells. J Clin Endocrinol Metab 86 (2001) 1387-1393